Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC1
|
ENSG00000177374.8 | HIC ZBTB transcriptional repressor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_1957170_1957392 | HIC1 | 167 | 0.881236 | 0.79 | 1.2e-02 | Click! |
chr17_1962756_1962907 | HIC1 | 3227 | 0.113234 | 0.77 | 1.5e-02 | Click! |
chr17_1963661_1963812 | HIC1 | 4132 | 0.101828 | 0.70 | 3.6e-02 | Click! |
chr17_1974773_1974924 | HIC1 | 15244 | 0.084537 | 0.68 | 4.4e-02 | Click! |
chr17_1973682_1973833 | HIC1 | 14153 | 0.085005 | -0.66 | 5.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_123301508_123301659 | 0.43 |
AP000783.1 |
Uncharacterized protein |
525 |
0.83 |
chr8_145598133_145598292 | 0.39 |
ADCK5 |
aarF domain containing kinase 5 |
462 |
0.57 |
chr15_101499460_101499680 | 0.35 |
LRRK1 |
leucine-rich repeat kinase 1 |
40020 |
0.15 |
chr17_79297430_79297605 | 0.33 |
TMEM105 |
transmembrane protein 105 |
6698 |
0.14 |
chr11_126242895_126243350 | 0.33 |
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
17253 |
0.15 |
chr22_46287916_46288067 | 0.33 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
80604 |
0.07 |
chr10_79470908_79471170 | 0.31 |
ENSG00000199664 |
. |
65774 |
0.1 |
chr8_142120178_142120491 | 0.31 |
DENND3 |
DENN/MADD domain containing 3 |
7043 |
0.22 |
chr3_15373334_15373485 | 0.30 |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
658 |
0.64 |
chr12_96588798_96589434 | 0.30 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
724 |
0.7 |
chr5_72921550_72921718 | 0.30 |
ARHGEF28 |
Rho guanine nucleotide exchange factor (GEF) 28 |
349 |
0.89 |
chr11_46259555_46259706 | 0.30 |
CTD-2589M5.4 |
|
36468 |
0.14 |
chr19_34895303_34895698 | 0.29 |
PDCD2L |
programmed cell death 2-like |
211 |
0.9 |
chr6_105627463_105627645 | 0.29 |
POPDC3 |
popeye domain containing 3 |
181 |
0.92 |
chr4_187112479_187112630 | 0.28 |
AC110771.1 |
Uncharacterized protein |
72 |
0.56 |
chr1_156084644_156084795 | 0.27 |
LMNA |
lamin A/C |
206 |
0.89 |
chr10_91597567_91597772 | 0.27 |
KIF20B |
kinesin family member 20B |
136233 |
0.05 |
chr17_5014893_5015044 | 0.27 |
ZNF232 |
zinc finger protein 232 |
168 |
0.53 |
chr19_38183197_38183429 | 0.26 |
ZFP30 |
ZFP30 zinc finger protein |
75 |
0.51 |
chr22_43390991_43391142 | 0.26 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
7380 |
0.22 |
chr5_142784532_142784876 | 0.26 |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
184 |
0.97 |
chr2_149403364_149403515 | 0.26 |
EPC2 |
enhancer of polycomb homolog 2 (Drosophila) |
450 |
0.9 |
chr7_150020672_150020823 | 0.26 |
ACTR3C |
ARP3 actin-related protein 3 homolog C (yeast) |
11 |
0.84 |
chr1_181056660_181057120 | 0.25 |
IER5 |
immediate early response 5 |
748 |
0.71 |
chr8_142219061_142219212 | 0.25 |
DENND3 |
DENN/MADD domain containing 3 |
16706 |
0.15 |
chr18_12911957_12912108 | 0.25 |
PTPN2 |
protein tyrosine phosphatase, non-receptor type 2 |
17610 |
0.19 |
chr10_121302384_121302535 | 0.25 |
RGS10 |
regulator of G-protein signaling 10 |
239 |
0.95 |
chr7_139875650_139875801 | 0.25 |
KDM7A |
lysine (K)-specific demethylase 7A |
1016 |
0.41 |
chr4_142558013_142558295 | 0.25 |
IL15 |
interleukin 15 |
54 |
0.99 |
chr16_70414920_70415071 | 0.25 |
RP11-529K1.4 |
|
1635 |
0.26 |
chr17_19265786_19266015 | 0.24 |
B9D1 |
B9 protein domain 1 |
11 |
0.96 |
chr5_134871706_134871930 | 0.24 |
NEUROG1 |
neurogenin 1 |
179 |
0.95 |
chr14_64320021_64320383 | 0.24 |
SYNE2 |
spectrin repeat containing, nuclear envelope 2 |
470 |
0.83 |
chr16_57513363_57513621 | 0.24 |
DOK4 |
docking protein 4 |
225 |
0.9 |
chr17_79019370_79019521 | 0.24 |
BAIAP2 |
BAI1-associated protein 2 |
7717 |
0.13 |
chr16_11517843_11518143 | 0.24 |
CTD-3088G3.8 |
Protein LOC388210 |
25627 |
0.11 |
chr22_39688482_39688637 | 0.24 |
RP3-333H23.8 |
|
434 |
0.73 |
chr3_185531495_185531680 | 0.24 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
7262 |
0.24 |
chr11_62554232_62554383 | 0.24 |
RP11-727F15.12 |
|
50 |
0.86 |
chr3_169386259_169386493 | 0.24 |
MECOM |
MDS1 and EVI1 complex locus |
5118 |
0.19 |
chr17_4891121_4891272 | 0.23 |
RP5-1050D4.5 |
|
195 |
0.5 |
chr14_65016574_65016725 | 0.23 |
PPP1R36 |
protein phosphatase 1, regulatory subunit 36 |
29 |
0.96 |
chr2_113915138_113915289 | 0.23 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
16335 |
0.13 |
chr9_139538749_139539009 | 0.23 |
EGFL7 |
EGF-like-domain, multiple 7 |
14429 |
0.09 |
chr8_81490427_81490652 | 0.23 |
ENSG00000223327 |
. |
7469 |
0.23 |
chr15_66914780_66915271 | 0.23 |
RP11-321F6.1 |
HCG2003567; Uncharacterized protein |
40497 |
0.12 |
chr14_101588217_101588492 | 0.23 |
ENSG00000206761 |
. |
23678 |
0.04 |
chr4_1728974_1729134 | 0.23 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
1077 |
0.43 |
chr13_24153750_24153949 | 0.23 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
330 |
0.93 |
chr9_135117273_135117424 | 0.23 |
ENSG00000221105 |
. |
27086 |
0.2 |
chr19_36822233_36822591 | 0.22 |
ENSG00000222730 |
. |
1061 |
0.46 |
chr5_139127106_139127386 | 0.22 |
ENSG00000200756 |
. |
29571 |
0.16 |
chr9_96919191_96919602 | 0.22 |
ENSG00000199165 |
. |
18838 |
0.15 |
chr10_80886709_80887280 | 0.22 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
58202 |
0.14 |
chr11_46354904_46355055 | 0.22 |
DGKZ |
diacylglycerol kinase, zeta |
524 |
0.74 |
chr22_43328839_43329007 | 0.22 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
12956 |
0.22 |
chr1_12678566_12678717 | 0.22 |
DHRS3 |
dehydrogenase/reductase (SDR family) member 3 |
904 |
0.57 |
chr6_219821_220028 | 0.22 |
DUSP22 |
dual specificity phosphatase 22 |
71706 |
0.13 |
chr14_65321384_65321594 | 0.22 |
SPTB |
spectrin, beta, erythrocytic |
25066 |
0.14 |
chr22_20849650_20849801 | 0.22 |
KLHL22 |
kelch-like family member 22 |
357 |
0.53 |
chr11_74460077_74460228 | 0.22 |
RNF169 |
ring finger protein 169 |
239 |
0.89 |
chr3_77087795_77087946 | 0.22 |
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
1167 |
0.63 |
chr15_70556363_70556608 | 0.22 |
ENSG00000200216 |
. |
70910 |
0.13 |
chr8_1949218_1949470 | 0.22 |
KBTBD11 |
kelch repeat and BTB (POZ) domain containing 11 |
27300 |
0.21 |
chr13_33923903_33924198 | 0.22 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
711 |
0.73 |
chr8_59058998_59059219 | 0.22 |
FAM110B |
family with sequence similarity 110, member B |
151995 |
0.04 |
chr17_17684994_17685191 | 0.21 |
RAI1 |
retinoic acid induced 1 |
354 |
0.78 |
chr10_76513880_76514031 | 0.21 |
KAT6B |
K(lysine) acetyltransferase 6B |
71385 |
0.12 |
chr3_67704618_67704769 | 0.21 |
SUCLG2 |
succinate-CoA ligase, GDP-forming, beta subunit |
338 |
0.94 |
chr3_142840251_142840402 | 0.21 |
CHST2 |
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
2153 |
0.37 |
chr5_17402468_17402619 | 0.21 |
ENSG00000201715 |
. |
56818 |
0.16 |
chr11_64611961_64612112 | 0.21 |
CDC42BPG |
CDC42 binding protein kinase gamma (DMPK-like) |
5 |
0.96 |
chr3_9885063_9885214 | 0.21 |
RPUSD3 |
RNA pseudouridylate synthase domain containing 3 |
488 |
0.64 |
chr3_176938963_176939114 | 0.21 |
TBL1XR1 |
transducin (beta)-like 1 X-linked receptor 1 |
23777 |
0.24 |
chr22_38136040_38136191 | 0.21 |
TRIOBP |
TRIO and F-actin binding protein |
6120 |
0.13 |
chr8_144479919_144480248 | 0.21 |
RP11-909N17.2 |
|
14836 |
0.09 |
chr3_12329938_12330144 | 0.21 |
PPARG |
peroxisome proliferator-activated receptor gamma |
296 |
0.94 |
chr4_2420730_2420881 | 0.21 |
ZFYVE28 |
zinc finger, FYVE domain containing 28 |
415 |
0.83 |
chr17_79093173_79093330 | 0.21 |
ENSG00000207736 |
. |
5922 |
0.1 |
chr11_118305737_118305934 | 0.21 |
RP11-770J1.4 |
|
86 |
0.93 |
chr19_7566190_7566368 | 0.21 |
C19orf45 |
chromosome 19 open reading frame 45 |
1751 |
0.19 |
chr9_132500262_132500413 | 0.21 |
PTGES |
prostaglandin E synthase |
14989 |
0.14 |
chr3_39425504_39425655 | 0.21 |
SLC25A38 |
solute carrier family 25, member 38 |
699 |
0.61 |
chr8_22722343_22722494 | 0.21 |
RP11-87E22.2 |
|
13067 |
0.17 |
chr13_37248035_37248273 | 0.21 |
SERTM1 |
serine-rich and transmembrane domain containing 1 |
105 |
0.98 |
chr10_105001357_105001535 | 0.20 |
RPEL1 |
ribulose-5-phosphate-3-epimerase-like 1 |
4198 |
0.21 |
chr7_156813832_156814124 | 0.20 |
MNX1-AS1 |
MNX1 antisense RNA 1 (head to head) |
10479 |
0.16 |
chr14_67999817_67999968 | 0.20 |
PLEKHH1 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
126 |
0.86 |
chr19_1401163_1401383 | 0.20 |
GAMT |
guanidinoacetate N-methyltransferase |
269 |
0.78 |
chr12_48340201_48340352 | 0.20 |
VDR |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
3445 |
0.2 |
chr20_32255046_32255197 | 0.20 |
NECAB3 |
N-terminal EF-hand calcium binding protein 3 |
656 |
0.4 |
chr7_76026926_76027201 | 0.20 |
ZP3 |
zona pellucida glycoprotein 3 (sperm receptor) |
228 |
0.92 |
chr14_55033500_55033670 | 0.20 |
SAMD4A |
sterile alpha motif domain containing 4A |
230 |
0.95 |
chr11_450644_450873 | 0.20 |
PTDSS2 |
phosphatidylserine synthase 2 |
478 |
0.63 |
chr14_91124792_91125085 | 0.20 |
TTC7B |
tetratricopeptide repeat domain 7B |
14386 |
0.16 |
chr22_46403312_46403647 | 0.20 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
30470 |
0.1 |
chr1_205638546_205638697 | 0.20 |
SLC45A3 |
solute carrier family 45, member 3 |
10966 |
0.15 |
chr4_1729881_1730032 | 0.20 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
175 |
0.93 |
chr5_178487503_178487654 | 0.20 |
ZNF354C |
zinc finger protein 354C |
162 |
0.96 |
chr8_22604778_22604955 | 0.20 |
ENSG00000253125 |
. |
150 |
0.96 |
chr4_109683560_109683768 | 0.20 |
ETNPPL |
ethanolamine-phosphate phospho-lyase |
27 |
0.98 |
chr16_57660984_57661135 | 0.19 |
GPR56 |
G protein-coupled receptor 56 |
564 |
0.69 |
chr8_22560866_22561017 | 0.19 |
EGR3 |
early growth response 3 |
10126 |
0.13 |
chr6_143268405_143268556 | 0.19 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
2142 |
0.4 |
chr2_102680238_102680787 | 0.19 |
IL1R1 |
interleukin 1 receptor, type I |
492 |
0.85 |
chr22_36853951_36854133 | 0.19 |
ENSG00000252225 |
. |
17027 |
0.13 |
chr1_19638140_19638327 | 0.19 |
AKR7A2 |
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
168 |
0.81 |
chr6_139350062_139350213 | 0.19 |
ABRACL |
ABRA C-terminal like |
158 |
0.97 |
chr20_13976641_13976793 | 0.19 |
MACROD2 |
MACRO domain containing 2 |
307 |
0.55 |
chr15_70440007_70440428 | 0.19 |
ENSG00000200216 |
. |
45358 |
0.16 |
chr11_4208528_4208828 | 0.19 |
RRM1-AS1 |
RRM1 antisense RNA 1 |
49191 |
0.14 |
chr22_50618466_50618746 | 0.19 |
TRABD |
TraB domain containing |
5738 |
0.09 |
chr10_80725065_80725216 | 0.19 |
ZMIZ1-AS1 |
ZMIZ1 antisense RNA 1 |
2989 |
0.39 |
chr10_73847993_73848144 | 0.19 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
18 |
0.98 |
chr3_186078642_186078793 | 0.19 |
DGKG |
diacylglycerol kinase, gamma 90kDa |
1029 |
0.66 |
chr1_51435046_51435197 | 0.19 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
495 |
0.82 |
chr2_112895757_112895915 | 0.19 |
FBLN7 |
fibulin 7 |
126 |
0.97 |
chr17_25893405_25893556 | 0.19 |
KSR1 |
kinase suppressor of ras 1 |
16467 |
0.2 |
chr22_50913528_50913679 | 0.19 |
SBF1 |
SET binding factor 1 |
149 |
0.9 |
chr2_211089697_211089892 | 0.19 |
ACADL |
acyl-CoA dehydrogenase, long chain |
421 |
0.83 |
chr12_120763625_120763877 | 0.18 |
PLA2G1B |
phospholipase A2, group IB (pancreas) |
145 |
0.93 |
chr11_46259289_46259440 | 0.18 |
CTD-2589M5.4 |
|
36734 |
0.14 |
chr19_18575570_18575881 | 0.18 |
ELL |
elongation factor RNA polymerase II |
11018 |
0.1 |
chr6_107440312_107440463 | 0.18 |
BEND3 |
BEN domain containing 3 |
3914 |
0.26 |
chr19_949007_949193 | 0.18 |
ARID3A |
AT rich interactive domain 3A (BRIGHT-like) |
16591 |
0.07 |
chr13_42032226_42032428 | 0.18 |
RGCC |
regulator of cell cycle |
632 |
0.67 |
chr6_35420284_35420435 | 0.18 |
FANCE |
Fanconi anemia, complementation group E |
221 |
0.93 |
chr5_785429_785580 | 0.18 |
ZDHHC11B |
zinc finger, DHHC-type containing 11B |
18437 |
0.18 |
chr5_141348457_141348608 | 0.18 |
RNF14 |
ring finger protein 14 |
72 |
0.96 |
chr3_58652897_58653052 | 0.18 |
FAM3D |
family with sequence similarity 3, member D |
399 |
0.87 |
chr20_31045349_31045530 | 0.18 |
RP5-1184F4.5 |
|
7881 |
0.18 |
chr14_24867552_24867703 | 0.18 |
NYNRIN |
NYN domain and retroviral integrase containing |
365 |
0.75 |
chr16_1980217_1980428 | 0.18 |
HS3ST6 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
11881 |
0.06 |
chr8_134308968_134309186 | 0.18 |
NDRG1 |
N-myc downstream regulated 1 |
258 |
0.95 |
chr11_315885_316036 | 0.18 |
IFITM1 |
interferon induced transmembrane protein 1 |
2107 |
0.12 |
chr12_120426741_120426892 | 0.18 |
CCDC64 |
coiled-coil domain containing 64 |
857 |
0.66 |
chr14_103557693_103557921 | 0.18 |
RP11-736N17.8 |
|
3253 |
0.21 |
chr7_129912749_129913103 | 0.18 |
CPA2 |
carboxypeptidase A2 (pancreatic) |
6259 |
0.15 |
chr9_38622054_38622296 | 0.18 |
FAM201A |
family with sequence similarity 201, member A |
1090 |
0.44 |
chr19_44111918_44112330 | 0.18 |
SRRM5 |
serine/arginine repetitive matrix 5 |
4129 |
0.09 |
chrX_101906739_101906890 | 0.18 |
GPRASP1 |
G protein-coupled receptor associated sorting protein 1 |
485 |
0.76 |
chr17_34842791_34842942 | 0.18 |
ZNHIT3 |
zinc finger, HIT-type containing 3 |
294 |
0.85 |
chr7_48075139_48075366 | 0.18 |
C7orf57 |
chromosome 7 open reading frame 57 |
135 |
0.96 |
chr6_50818677_50818828 | 0.18 |
TFAP2B |
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
32313 |
0.25 |
chr2_54667400_54667551 | 0.18 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
15947 |
0.24 |
chr10_103990547_103990698 | 0.18 |
PITX3 |
paired-like homeodomain 3 |
1218 |
0.37 |
chr17_48351036_48351238 | 0.17 |
TMEM92 |
transmembrane protein 92 |
651 |
0.61 |
chr14_61788792_61788943 | 0.17 |
PRKCH |
protein kinase C, eta |
432 |
0.62 |
chr13_98795842_98795993 | 0.17 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
183 |
0.95 |
chr19_16571490_16571641 | 0.17 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
11189 |
0.12 |
chr8_134664602_134664753 | 0.17 |
ENSG00000212273 |
. |
7709 |
0.31 |
chr18_45936153_45936382 | 0.17 |
ZBTB7C |
zinc finger and BTB domain containing 7C |
474 |
0.84 |
chr3_128839994_128840145 | 0.17 |
RAB43 |
RAB43, member RAS oncogene family |
555 |
0.64 |
chr20_57581666_57581817 | 0.17 |
CTSZ |
cathepsin Z |
561 |
0.7 |
chr11_13300235_13300386 | 0.17 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
878 |
0.72 |
chr1_45793013_45793296 | 0.17 |
HPDL |
4-hydroxyphenylpyruvate dioxygenase-like |
609 |
0.67 |
chr17_17685761_17685912 | 0.17 |
RAI1 |
retinoic acid induced 1 |
390 |
0.76 |
chr10_126749541_126749767 | 0.17 |
ENSG00000264572 |
. |
28215 |
0.18 |
chr11_57243945_57244096 | 0.17 |
RP11-624G17.3 |
|
987 |
0.35 |
chr15_70873167_70873332 | 0.17 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
121371 |
0.06 |
chr12_107713372_107713523 | 0.17 |
BTBD11 |
BTB (POZ) domain containing 11 |
228 |
0.96 |
chr5_170738876_170739099 | 0.17 |
TLX3 |
T-cell leukemia homeobox 3 |
2699 |
0.26 |
chr17_1655742_1656238 | 0.17 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
9263 |
0.1 |
chr5_172659783_172660057 | 0.17 |
NKX2-5 |
NK2 homeobox 5 |
2289 |
0.28 |
chr15_57591994_57592162 | 0.17 |
TCF12 |
transcription factor 12 |
17425 |
0.21 |
chr10_35069926_35070077 | 0.17 |
PARD3 |
par-3 family cell polarity regulator |
34248 |
0.18 |
chr20_61087234_61087385 | 0.17 |
GATA5 |
GATA binding protein 5 |
36283 |
0.11 |
chr6_143998810_143998977 | 0.17 |
PHACTR2 |
phosphatase and actin regulator 2 |
209 |
0.96 |
chr22_31741186_31741337 | 0.17 |
PATZ1 |
POZ (BTB) and AT hook containing zinc finger 1 |
501 |
0.64 |
chr4_7057020_7057288 | 0.17 |
TADA2B |
transcriptional adaptor 2B |
2074 |
0.21 |
chr22_46973599_46973750 | 0.17 |
GRAMD4 |
GRAM domain containing 4 |
648 |
0.75 |
chrX_69653934_69654085 | 0.17 |
DLG3 |
discs, large homolog 3 (Drosophila) |
10702 |
0.14 |
chr19_6243165_6243316 | 0.17 |
CTC-503J8.4 |
|
15928 |
0.14 |
chr11_7534597_7534748 | 0.17 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
143 |
0.91 |
chr5_159107_159571 | 0.17 |
ENSG00000199540 |
. |
15027 |
0.14 |
chr3_46185448_46185808 | 0.17 |
CCR3 |
chemokine (C-C motif) receptor 3 |
19468 |
0.21 |
chr15_83316548_83316788 | 0.16 |
CPEB1 |
cytoplasmic polyadenylation element binding protein 1 |
60 |
0.62 |
chr17_7486608_7486759 | 0.16 |
AC113189.5 |
|
153 |
0.47 |
chr11_126233884_126234182 | 0.16 |
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
8164 |
0.16 |
chr10_92922156_92922510 | 0.16 |
PCGF5 |
polycomb group ring finger 5 |
57575 |
0.16 |
chr17_64299023_64299202 | 0.16 |
PRKCA |
protein kinase C, alpha |
168 |
0.96 |
chr1_244012941_244013092 | 0.16 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
414 |
0.89 |
chr17_68165689_68166035 | 0.16 |
KCNJ2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
186 |
0.66 |
chr10_94179898_94180049 | 0.16 |
ENSG00000207895 |
. |
21088 |
0.21 |
chr15_90319837_90320135 | 0.16 |
MESP2 |
mesoderm posterior 2 homolog (mouse) |
397 |
0.79 |
chr3_55522536_55522942 | 0.16 |
WNT5A-AS1 |
WNT5A antisense RNA 1 |
1012 |
0.47 |
chr2_62592200_62592351 | 0.16 |
ENSG00000238809 |
. |
100145 |
0.07 |
chr2_231742152_231742309 | 0.16 |
AC012507.3 |
|
8985 |
0.17 |
chr22_20287333_20287484 | 0.16 |
XXbac-B444P24.13 |
|
18864 |
0.11 |
chr2_109745417_109745568 | 0.16 |
SH3RF3 |
SH3 domain containing ring finger 3 |
312 |
0.92 |
chr5_59189611_59189822 | 0.16 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
91 |
0.98 |
chr16_2630606_2630757 | 0.16 |
RP11-20I23.7 |
|
8327 |
0.07 |
chr10_100227678_100227852 | 0.16 |
HPS1 |
Hermansky-Pudlak syndrome 1 |
21082 |
0.19 |
chr12_53465850_53466141 | 0.16 |
SPRYD3 |
SPRY domain containing 3 |
7166 |
0.11 |
chr11_108368869_108369152 | 0.16 |
KDELC2 |
KDEL (Lys-Asp-Glu-Leu) containing 2 |
149 |
0.96 |
chr6_72129499_72129753 | 0.16 |
ENSG00000207827 |
. |
16302 |
0.22 |
chr10_3306842_3307061 | 0.16 |
PITRM1 |
pitrilysin metallopeptidase 1 |
91948 |
0.09 |
chr8_27695395_27695562 | 0.16 |
PBK |
PDZ binding kinase |
121 |
0.96 |
chr21_45585843_45585994 | 0.16 |
AP001055.1 |
|
7662 |
0.15 |
chr15_66914114_66914568 | 0.16 |
RP11-321F6.1 |
HCG2003567; Uncharacterized protein |
39813 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.2 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.2 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0042816 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0046084 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.1 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.0 | GO:0044256 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.0 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.0 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.0 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.2 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.0 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
0.0 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.0 | GO:0044557 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.2 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0045588 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.0 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.2 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0050812 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.2 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.0 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.0 | 0.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0046980 | tapasin binding(GO:0046980) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |